Why Multitarget Vasodilatory (Endo)cannabinoids Are Not Effective as Antihypertensive Compounds after Chronic Administration: Comparison of Their Effects on Systemic and Pulmonary Hypertension
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Why Multitarget Vasodilatory (Endo)cannabinoids Are Not Effective as Antihypertensive Compounds after Chronic Administration: Comparison of Their Effects on Systemic and Pulmonary Hypertension
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 15, Issue 9, Pages 1119
Publisher
MDPI AG
Online
2022-09-08
DOI
10.3390/ph15091119
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Burden of Resistant Hypertension Across the World
- (2022) Luisa Campos Caldeira Brant et al. CURRENT HYPERTENSION REPORTS
- The assessment of pulmonary arterial pressure and its clinical relevance: a 100-year journey from Europe, over the United States to Australia
- (2022) Gabor Kovacs et al. EUROPEAN RESPIRATORY JOURNAL
- A review of genetically-driven rodent models of pulmonary hypertension
- (2022) Magdalena Jasińska-Stroschein VASCULAR PHARMACOLOGY
- Sympathetic nervous system and hypertension: New evidences
- (2022) Gino Seravalle et al. AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL
- 2-Arachidonoylglycerol Attenuates Myocardial Fibrosis in Diabetic Mice Via the TGF-β1/Smad Pathway
- (2022) Zhengjie Chen et al. CARDIOVASCULAR DRUGS AND THERAPY
- Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation
- (2022) Tzu-Tang Wei et al. CELL
- Diagnosis and Treatment of Pulmonary Arterial Hypertension
- (2022) Nicole F. Ruopp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cannabidiol Improves Antioxidant Capacity and Reduces Inflammation in the Lungs of Rats with Monocrotaline-Induced Pulmonary Hypertension
- (2022) Anna Krzyżewska et al. MOLECULES
- Acute and long-term effects of cannabinoids on hypertension and kidney injury
- (2022) Daria Golosova et al. Scientific Reports
- Why Do Marijuana and Synthetic Cannabimimetics Induce Acute Myocardial Infarction in Healthy Young People?
- (2022) Jolanta Weresa et al. Cells
- Oxidative Stress in Arterial Hypertension (HTN): The Nuclear Factor Erythroid Factor 2-Related Factor 2 (Nrf2) Pathway, Implications and Future Perspectives
- (2022) Daniela Maria Tanase et al. Pharmaceutics
- Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice
- (2022) Amaya Austrich-Olivares et al. Pharmaceuticals
- Cross-Talk between the (Endo)Cannabinoid and Renin-Angiotensin Systems: Basic Evidence and Potential Therapeutic Significance
- (2022) Krzysztof Mińczuk et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A New Approach for the Development of Multiple Cardiovascular Risk Factors in Two Rat Models of Hypertension
- (2022) Karyne Garcia Tafarelo Moreno et al. Pharmaceuticals
- Effects of the peripheral CB1 receptor antagonist JD5037 in mono— and polytherapy with the AMPK activator metformin in a monocrotaline-induced rat model of pulmonary hypertension
- (2022) Patryk Remiszewski et al. Frontiers in Pharmacology
- GPR119 and GPR55 as Receptors for Fatty Acid Ethanolamides, Oleoylethanolamide and Palmitoylethanolamide
- (2021) Dong-Soon Im INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Endocannabinoid System and PPARs: Focus on Their Signalling Crosstalk, Action and Transcriptional Regulation
- (2021) Fabio Arturo Iannotti et al. Cells
- Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances
- (2021) Bradley A Maron et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Animal models of pulmonary hypertension: Getting to the heart of the problem
- (2021) Joshua P. Dignam et al. BRITISH JOURNAL OF PHARMACOLOGY
- Role of the Peroxisome Proliferator Activated Receptors in Hypertension
- (2021) Shi Fang et al. CIRCULATION RESEARCH
- Pathophysiology of Hypertension
- (2021) David G. Harrison et al. CIRCULATION RESEARCH
- Peripheral CB1R as a modulator of metabolic inflammation
- (2021) Ji Hye Han et al. FASEB JOURNAL
- Palmitoylethanolamide: A Natural Compound for Health Management
- (2021) Paul Clayton et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Beneficial Changes in Rat Vascular Endocannabinoid System in Primary Hypertension and under Treatment with Chronic Inhibition of Fatty Acid Amide Hydrolase by URB597
- (2021) Marta Baranowska-Kuczko et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Rodent models of hypertension
- (2021) Hamdi A. Jama et al. BRITISH JOURNAL OF PHARMACOLOGY
- THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
- (2021) Stephen PH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain
- (2021) Barbara Stella et al. DRUGS
- Cannabinoid Receptors in Myocardial Injury: A Brother Born to Rival
- (2021) Xinru Tang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabinoids—A New Perspective in Adjuvant Therapy for Pulmonary Hypertension
- (2021) Anna Krzyżewska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
- (2021) Henry Lowe et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Endocannabinoid System and Cannabidiol: Past, Present, and Prospective for Cardiovascular Diseases
- (2021) Martina Rabino et al. Pharmaceuticals
- The GPR18 Agonist PSB-KD-107 Exerts Endothelium-Dependent Vasorelaxant Effects
- (2021) Magdalena Kotańska et al. Pharmaceuticals
- Atualização no Tratamento da Hipertensão Arterial Pulmonar
- (2021) Caio J. Fernandes et al. Arquivos Brasileiros de Cardiologia
- An overview on plants cannabinoids endorsed with cardiovascular effects
- (2021) Marilisa Pia Dimmito et al. BIOMEDICINE & PHARMACOTHERAPY
- Targeting Oxidative Stress: Novel Coumarin-Based Inverse Agonists of GPR55
- (2021) Matthias Apweiler et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Diagnosis and treatment of arterial hypertension 2021
- (2021) Christian Ott et al. KIDNEY INTERNATIONAL
- Pulmonary Arterial Hypertension
- (2021) Paul M. Hassoun NEW ENGLAND JOURNAL OF MEDICINE
- Salt-Sensitivity of Blood Pressure and Insulin Resistance
- (2021) Lale A. Ertuglu et al. Frontiers in Physiology
- Vasoprotective Endothelial Effects of Chronic Cannabidiol Treatment and Its Influence on the Endocannabinoid System in Rats with Primary and Secondary Hypertension
- (2021) Marta Baranowska-Kuczko et al. Pharmaceuticals
- Current and future treatments of pulmonary arterial hypertension
- (2020) Natascha Sommer et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pathophysiology of Hypertensive Heart Disease: Beyond Left Ventricular Hypertrophy
- (2020) Chike C. Nwabuo et al. CURRENT HYPERTENSION REPORTS
- Chronic Cannabidiol Administration Fails to Diminish Blood Pressure in Rats with Primary and Secondary Hypertension Despite Its Effects on Cardiac and Plasma Endocannabinoid System, Oxidative Stress and Lipid Metabolism
- (2020) Patryk Remiszewski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabinoid type 2 receptor agonist JWH133 decreases blood pressure of spontaneously hypertensive rats through relieving inflammation in the rostral ventrolateral medulla of the brain
- (2020) He-Kai Shi et al. JOURNAL OF HYPERTENSION
- The challenge of an expanded therapeutic window in pulmonary hypertension
- (2020) Simon Stewart et al. Nature Reviews Cardiology
- The global epidemiology of hypertension
- (2020) Katherine T. Mills et al. Nature Reviews Nephrology
- The therapeutic potential of second and third generation CB1R antagonists
- (2020) Resat Cinar et al. PHARMACOLOGY & THERAPEUTICS
- Effects of hypertension and FAAH inhibitor treatment of rats with primary and secondary hypertension considering the physicochemical properties of erythrocytes
- (2020) Izabela Dobrzyńska et al. TOXICOLOGY MECHANISMS AND METHODS
- Role of the renin–angiotensin system in kidney development and programming of adult blood pressure
- (2020) Lucas F. Almeida et al. CLINICAL SCIENCE
- A Guide to Targeting the Endocannabinoid System in Drug Design
- (2020) Adam Stasiulewicz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Novel Alternative in the Treatment of Detrusor Overactivity? In Vivo Activity of O-1602, the Newly Synthesized Agonist of GPR55 and GPR18 Cannabinoid Receptors
- (2020) Andrzej Wróbel et al. MOLECULES
- Experimental Activation of Endocannabinoid System Reveals Antilipotoxic Effects on Cardiac Myocytes
- (2020) Ewa Harasim-Symbor et al. MOLECULES
- Endothelial TRPV1 as an Emerging Molecular Target to Promote Therapeutic Angiogenesis
- (2020) Sharon Negri et al. Cells
- Monocrotaline-induced liver toxicity in rat predicted by a combined in vitro physiologically based kinetic modeling approach
- (2020) Suparmi Suparmi et al. ARCHIVES OF TOXICOLOGY
- The endocannabinoid system
- (2020) Aruna Kilaru et al. Essays in Biochemistry
- Stimulation of atypical cannabinoid receptor GPR55 abolishes the symptoms of detrusor overactivity in spontaneously hypertensive rats
- (2020) Andrzej Wróbel et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The Impact of Marijuana on the Cardiovascular System: A Review of the Most Common Cardiovascular Events Associated with Marijuana Use
- (2020) Zara Latif et al. Journal of Clinical Medicine
- The FAAH Inhibitor URB597 Modulates Lipid Mediators in the Brain of Rats with Spontaneous Hypertension
- (2020) Michał Biernacki et al. Biomolecules
- Cannabidiol Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats
- (2020) Olga Sadowska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease
- (2020) Aleksandra Kicman et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Therapeutic Exploitation of GPR18: Beyond the Cannabinoids?
- (2020) Paula Morales et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pulmonary Hypertension: A Brief Guide for Clinicians
- (2020) Stacy A. Mandras et al. MAYO CLINIC PROCEEDINGS
- Evaluation and management of pulmonary arterial hypertension
- (2020) Sarah Beshay et al. RESPIRATORY MEDICINE
- Perivascular Inflammation in Pulmonary Arterial Hypertension
- (2020) Yijie Hu et al. Cells
- Toward Better Reproducibility in Experimental Research on New Agents for Pulmonary Hypertension. An Analysis of Data from Four Hundred Animal Studies
- (2020) Magdalena Jasińska-Stroschein CARDIOVASCULAR DRUGS AND THERAPY
- The endocannabinoid system – current implications for drug development
- (2020) C.J. Fowler JOURNAL OF INTERNAL MEDICINE
- Chronic cannabidiol treatment reduces the carbachol-induced coronary constriction and left ventricular cardiomyocyte width of the isolated hypertensive rat heart
- (2020) Anna Pędzińska-Betiuk et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Central nervous system, peripheral and hemodynamic effects of nanoformulated anandamide in hypertension
- (2020) Virna Margarita Martín Giménez et al. Advances in Medical Sciences
- Animal Models of Hypertension: A Scientific Statement From the American Heart Association
- (2019) Lilach O. Lerman et al. HYPERTENSION
- The new haemodynamic definition of pulmonary hypertension: evidence prevails, finally!
- (2019) Marius M. Hoeper et al. EUROPEAN RESPIRATORY JOURNAL
- Cannabinoid-sensitive receptors in cardiac health and disease
- (2019) Sarah-Lena Puhl BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Cannabis and Cardiovascular Disease
- (2019) Moyukh Ghosh et al. Current Atherosclerosis Reports
- Cannabidiol Affects the Bezold-Jarisch Reflex via TRPV1 and 5-HT3 Receptors and Has Peripheral Sympathomimetic Effects in Spontaneously Hypertensive and Normotensive Rats
- (2019) Rafał Kossakowski et al. Frontiers in Pharmacology
- Anandamide-nanoformulation obtained by electrospraying for cardiovascular therapy
- (2019) Virna Margarita Martín Giménez et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Potential metabolic and behavioural roles of the putative endocannabinoid receptors GPR18, GPR55 and GPR119 in feeding
- (2019) Ricardo E. Ramírez-Orozco et al. Current Neuropharmacology
- Vasodilatory effects of cannabidiol in human pulmonary and rat small mesenteric arteries
- (2019) Marta Baranowska-Kuczko et al. JOURNAL OF HYPERTENSION
- Cannabinoids and the expanded endocannabinoid system in neurological disorders
- (2019) Luigia Cristino et al. Nature Reviews Neurology
- Antioxidative and Anti-Inflammatory Properties of Cannabidiol
- (2019) Sinemyiz Atalay et al. Antioxidants
- Cannabinoids in arterial, pulmonary and portal hypertension - mechanisms of action and potential therapeutic significance
- (2018) Barbara Malinowska et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Endocannabinoid System Affects Myocardial Glucose Metabolism in the DOCA-Salt Model of Hypertension
- (2018) Agnieszka Polak et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- PPAR Agonists and Metabolic Syndrome: An Established Role?
- (2018) Margherita Botta et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Enhanced endocannabinoid tone as a potential target of pharmacotherapy
- (2018) Marek Toczek et al. LIFE SCIENCES
- Redox system and phospholipid metabolism in the kidney of hypertensive rats after FAAH inhibitor URB597 administration
- (2018) Michał Biernacki et al. Redox Biology
- Hypertension
- (2018) Suzanne Oparil et al. Nature Reviews Disease Primers
- LH-21, A Peripheral Cannabinoid Receptor 1 Antagonist, Exerts Favorable Metabolic Modulation Including Antihypertensive Effect in KKAy Mice by Regulating Inflammatory Cytokines and Adipokines on Adipose Tissue
- (2018) Ziqi Dong et al. Frontiers in Endocrinology
- Arterial hypertension
- (2018) Jens Jordan et al. Deutsches Arzteblatt International
- The Effect of Long-Term Administration of Fatty Acid Amide Hydrolase Inhibitor URB597 on Oxidative Metabolism in the Heart of Rats with Primary and Secondary Hypertension
- (2018) Michał Biernacki et al. MOLECULES
- New approaches and challenges to targeting the endocannabinoid system
- (2018) Vincenzo Di Marzo NATURE REVIEWS DRUG DISCOVERY
- Hypertension and chronic inhibition of endocannabinoid degradation modify the endocannabinoid system and redox balance in rat heart and plasma
- (2018) Michał Biernacki et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Fatty acid amide hydrolase inhibitor (URB597) as a regulator of myocardial lipid metabolism in spontaneously hypertensive rats
- (2018) Ewa Harasim-Symbor et al. CHEMISTRY AND PHYSICS OF LIPIDS
- Medical Use of Cannabinoids
- (2018) Ana Isabel Fraguas-Sánchez et al. DRUGS
- Haemodynamic definitions and updated clinical classification of pulmonary hypertension
- (2018) Gérald Simonneau et al. EUROPEAN RESPIRATORY JOURNAL
- Changes in physicochemical properties of kidney cells membrane as a consequence of hypertension and treatment of hypertensive rats with FAAH inhibitor
- (2018) Izabela Dobrzyńska et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Long-term administration of fatty acid amide hydrolase inhibitor (URB597) to rats with spontaneous hypertension disturbs liver redox balance and phospholipid metabolism
- (2018) Michał Biernacki et al. Advances in Medical Sciences
- A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension
- (2017) David Kylhammar et al. EUROPEAN HEART JOURNAL
- Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model
- (2017) Marius M. Hoeper et al. EUROPEAN RESPIRATORY JOURNAL
- TRPV 1 channels in cardiovascular system: A double edged sword?
- (2017) Puneet Kaur Randhawa et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The Effect of Chronic Activation of the Novel Endocannabinoid Receptor GPR18 on Myocardial Function and Blood Pressure in Conscious Rats
- (2017) Asmaa I. Matouk et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- The effects of chronic FAAH inhibition on myocardial lipid metabolism in normotensive and DOCA-salt hypertensive rats
- (2017) Agnieszka Polak et al. LIFE SCIENCES
- Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly
- (2017) Pal Pacher et al. Nature Reviews Cardiology
- Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?
- (2017) Cecilia J Hillard NEUROPSYCHOPHARMACOLOGY
- Animal models of pulmonary arterial hypertension: A systematic review and meta-analysis of data from 6126 animals
- (2017) Katarzyna Sztuka et al. PHARMACOLOGICAL RESEARCH
- Cannabidiol: State of the art and new challenges for therapeutic applications
- (2017) Simona Pisanti et al. PHARMACOLOGY & THERAPEUTICS
- The Hypertension Pandemic: An Evolutionary Perspective
- (2017) Bernard C. Rossier et al. PHYSIOLOGY
- The influence of DOCA-salt hypertension and chronic administration of the FAAH inhibitor URB597 on K Ca 2.3/K Ca 3.1-EDH-type relaxation in rat small mesenteric arteries
- (2017) Monika Kloza et al. VASCULAR PHARMACOLOGY
- An update on PPAR activation by cannabinoids
- (2016) Saoirse Elizabeth O'Sullivan BRITISH JOURNAL OF PHARMACOLOGY
- Protective role of cannabinoid CB 1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats
- (2016) Marta Baranowska-Kuczko et al. LIFE SCIENCES
- Age-specific influences of chronic administration of the fatty acid amide hydrolase inhibitor URB597 on cardiovascular parameters and organ hypertrophy in DOCA-salt hypertensive rats
- (2016) Marek Toczek et al. Pharmacological Reports
- Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats
- (2016) Michał Biernacki et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Enhanced vasorelaxation effect of endogenous anandamide on thoracic aorta in renal vascular hypertension rats
- (2015) Zan Guo et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Palmitoylethanolamide Treatment Reduces Blood Pressure in Spontaneously Hypertensive Rats: Involvement of Cytochrome P450-Derived Eicosanoids and Renin Angiotensin System
- (2015) Giuseppina Mattace Raso et al. PLoS One
- Vascular targets for cannabinoids: animal and human studies
- (2013) Christopher Stanley et al. BRITISH JOURNAL OF PHARMACOLOGY
- Modulation by 17β-estradiol of anandamide vasorelaxation in normotensive and hypertensive rats: A role for TRPV1 but not fatty acid amide hydrolase
- (2013) W.-S.V. Ho EUROPEAN JOURNAL OF PHARMACOLOGY
- N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress
- (2013) Giuseppina Mattace Raso et al. PHARMACOLOGICAL RESEARCH
- Endocannabinoid anandamide mediates hypoxic pulmonary vasoconstriction
- (2013) D. Wenzel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Triphasic blood pressure responses to cannabinoids: do we understand the mechanism?
- (2011) Barbara Malinowska et al. BRITISH JOURNAL OF PHARMACOLOGY
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
- (2010) R. G. Pertwee et al. PHARMACOLOGICAL REVIEWS
- CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes
- (2009) Partha Mukhopadhyay et al. CARDIOVASCULAR RESEARCH
- Effect of rimonabant on blood pressure in overweight/obese patients with/without co-morbidities: analysis of pooled RIO study results
- (2009) Luis M Ruilope et al. JOURNAL OF HYPERTENSION
- ‘Entourage’ effects ofN-palmitoylethanolamide andN-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors
- (2008) W-SV Ho et al. BRITISH JOURNAL OF PHARMACOLOGY
- Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study †
- (2008) Luc F. Van Gaal et al. EUROPEAN HEART JOURNAL
- Effects of hypertension on vasorelaxation to endocannabinoids in vitro
- (2008) Amanda J. Wheal et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effects of chronic nitric oxide synthase inhibition on the cardiovascular responses to cannabinoids in vivo and in vitro
- (2007) A J Wheal et al. BRITISH JOURNAL OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started